-+ 0.00%
-+ 0.00%
-+ 0.00%

Autonomix Medical wins new US patent for feedback-guided precision neuromodulation systems

PUBT·08/26/2026 12:31:21
Listen to the news
Autonomix Medical wins new US patent for feedback-guided precision neuromodulation systems
  • Autonomix Medical secured U.S. Patent No. 12,714,780, issued Aug. 25, 2026, covering feedback-guided precision neuromodulation systems.
  • Protection covers real-time physiological feedback to control therapy delivery, including sensing and imaging to guide treatment based on tissue response.
  • Claims include tumor-focused applications using therapeutic fluid to effect neural ablation aimed at reducing cancer pain.
  • Patent traces to a continuation application linked to filings from 2012 and 2014.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Autonomix Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608260830PRIMZONEFULLFEED9816182) on August 26, 2026, and is solely responsible for the information contained therein.